Concienciación
Conozca más sobre los esfuerzos de defensa de la Asociación para garantizar el acceso de los pacientes a las terapias.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
Sep 23, 2020
U.S. International Trade Commission Testimony on COVID-19 Related Goods
Oral Testimony of Amy C. Efantis, President & CEO, Plasma Protein Therapeutics Association Hearing on COVID-19 Related Goods: Conditions in the U.S. Industry and Key Supply Chains U.S. International Trade Commission.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa440e4694729840b893_PPTA_USITC_Testimony-COVID-19_.pdf
Sep 23, 2020
U.S. International Trade Commission Testimony on COVID-19 Related Goods
Oral Testimony of Amy C. Efantis, President & CEO, Plasma Protein Therapeutics Association Hearing on COVID-19 Related Goods: Conditions in the U.S. Industry and Key Supply Chains U.S. International Trade Commission.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa440e4694729840b893_PPTA_USITC_Testimony-COVID-19_.pdf
Sep 15, 2020
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64522eeace0c39bce531cdfd_%2315EMA20011a_IPFA-PPTA_letter_to_EMA_Donor_acceptance_Criteria15SEP2020_Final.pdf
Sep 15, 2020
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64522eeace0c39bce531cdfd_%2315EMA20011a_IPFA-PPTA_letter_to_EMA_Donor_acceptance_Criteria15SEP2020_Final.pdf
Aug 4, 2020
Proposed Urgent Regulatory Actions to Increase Source Plasma Collections
On behalf of the Plasma Protein Therapeutics Association (PPTA), we wish to commend the Department’s efforts to increase collections of convalescent plasma as a treatment for patients diagnosed with COVID-19.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64522f013303ce0a7b412d57_%2343-PPTA_Letter_to_HHS_Secretary_Azar_FINAL_08.04.2020.pdf
Aug 4, 2020
Proposed Urgent Regulatory Actions to Increase Source Plasma Collections
On behalf of the Plasma Protein Therapeutics Association (PPTA), we wish to commend the Department’s efforts to increase collections of convalescent plasma as a treatment for patients diagnosed with COVID-19.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64522f013303ce0a7b412d57_%2343-PPTA_Letter_to_HHS_Secretary_Azar_FINAL_08.04.2020.pdf
No results found